Myomo, Inc. Wins Product of the Year Award from the Massachusetts Technology Collaborative Leadership Council for its Neuro Robotic Device Used to Regain Arm Movemment
Myomo’s unique technology platform was developed at MIT in collaboration with experts from Harvard Medical School. The company is applying its technology to enable individuals with neurological conditions such as stroke, brain injuries, spinal cord injuries, multiple sclerosis and ALS to move again.
The Council selected Myomo as one of 15 finalists in the Product of the Year category. Products were displayed at the 14th annual MassTLC awards gala, which showcased the depth and breadth of the state’s vibrant technology ecosystem. Product of the Year was chosen by the nearly 500 senior executives in attendance, in a live vote via text message during the event. Finalists represented a wide array of technologies including software companies, mobile app developers, prosthetics and medical devices and Internet destinations.
“We’re honored to be able to give this award to Myomo,” said Tom Hopcroft, president and CEO of MassTLC. “Myomo’s innovative technology and market leadership is testimony to the outstanding achievements by the individuals and organizations in Massachusetts that are defining the future of the technology sector.”
“It is gratifying to have been selected by our peers to represent the innovative and cutting-edge work being done right here in Massachusetts. We thank the Mass Technology Leadership Council for this award,” said Paul R. Gudonis, chief executive officer, Myomo. “Myomo is helping stroke survivors and others affected by neurological and muscular conditions relearn muscle motion and regain quality of life, helping to advance patient care and improve outcomes. This recognition is an important milestone for our company.”
About the mPower Mobility System
The mPower Mobility System helps individuals with muscle weakness caused by neurological conditions such as stroke, brain and spinal cord injuries, multiple sclerosis and ALS regain range of motion in their arms. The mPower 1000 is an arm brace with a non-invasive human machine interface (HMI) that amplifies the weakened electrical signals in muscles in the arm, helping the patient to complete routine tasks. It works by sensing the body’s own muscle activity, and helps weak or paralyzed arm muscles relearn motion. The device provides appropriate assistance to enable desired motion, allowing the patient to relearn activities of daily living (i.e., lifting a glass to take a drink).
Myomo has also developed the PERL (Push-Eat-Reach-Lift) Technique, evidence-based treatment plans to maximize outcomes with the mPower 1000 device. The company is also developing mobile applications and virtual reality-based games to enhance therapeutic training and track and measure progress while using the device.
About The Mass Technology Leadership Council
The Mass Technology Leadership Council, Inc. is the only business association that addresses the critical leadership issues of innovative technology and technology-enabled companies. The organization is dedicated to fostering entrepreneurship and promoting the success of companies that develop and deploy technology across industry sectors. The Mass Technology Leadership Council conducts educational programs, hosts industry events, facilitates networking, sponsors research, advocates in favor of technology policies that promote innovation, entrepreneurship and competition, and recognizes industry-leading companies and people. For more information, visit www.masstlc.org.
About Myomo
Myomo is a new generation medical device company that combines innovative robotics technology with leading rehabilitation expertise to revolutionize stroke therapy. Myomo's technology was originally developed at Massachusetts Institute of Technology (MIT) in collaboration with medical experts affiliated with Harvard Medical School. Our mission is to help restore independence for individuals who suffer from debilitating muscle weakness due to neurological conditions. The Myomo mPower Mobiltiy System has received marketing clearance from the U.S. Food and Drug Administration (FDA) and is designed to enable individuals to self-initiate and control movement of partially paralyzed limbs using their own biological signals. With this capability, Myomo helps people relearn how to move affected muscles and restore movement to their arms. For more information visit, www.myomo.com